Cleared Traditional

K993014 - MODIFICATION TO DOCUMENT THYROID CAL.VER

K993014 is an FDA 510(k) clearance for MODIFICATION TO DOCUMENT THYROID CAL.VER, manufactured by Casco-Nerl Diagnostics Corporation (Maine). The device is a Class 1 Immunology device with product code JJY cleared through the Traditional 510(k) pathway after a 79-day FDA review.

K993014 · Casco-Nerl Diagnostics Corporation (Maine) · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1999
Decision
79d
Days
Class 1
Risk

K993014 is an FDA 510(k) clearance for the MODIFICATION TO DOCUMENT THYROID CAL.VER. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Casco-Nerl Diagnostics Corporation (Maine) (Portland, US). The FDA issued a Cleared decision on November 26, 1999 after a review of 79 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Casco-Nerl Diagnostics Corporation (Maine) devices

FDA 510(k) Submission Details - K993014

510(k) Number K993014 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 08, 1999
Decision Date November 26, 1999
Days to Decision 79 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
26d faster than avg
Panel avg: 105d · This submission: 79d
Pathway characteristics
Predicate-based equivalence.

JJY Device Classification - Class 1, General Controls

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 584
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K993014.
QUALITROL TUMOR MARKER CONTROL, LEVELS 1 AND 2
K993631 · Seracare Technology · Dec 1999
APOLIPOPROTEIN CONTROL SERUM CHD, MODEL OUPH
K993310 · Dade Behring, Inc. · Nov 1999
TRI-POINT, LIQUIMMUNE LIQUID ASSAYED IMMUNOASSAY CONTROL, LEVELS 1, 2, AND 3
K993546 · Medical Analysis Systems, Inc. · Nov 1999
SYNCHRON SYSTEMS OP 300 LOW AND HIGH URINE CONTROLS
K993023 · Beckman Coulter, Inc. · Nov 1999
ABBOTT ARCHITECH GLYCATED HEMOGLOBIN MASTERCHECK
K992710 · Abbott Laboratories · Nov 1999
PRECINORM UNIVERSAL AND PRECIPATH UNIVERSAL CONTROL SERA
K992900 · Roche Diagnostics Corp. · Nov 1999